Combined Synopsis/Solicitation & Notice of Intent to Sole Source to Tradespace for Subscription

The Food and Drug Administration Office of Acquisition and Grant Services seeks subscription-based access to an intellectual property lifecycle management and market intelligence platform, with responses due September 22, 2026, at 3:00 PM Eastern Time. This is a sole-source procurement to Tradespace Inc.; no competitive quotes are being solicited and "or equal" products will not be accepted.

Place of performance is Silver Spring, Maryland. The FDA's Technology Transfer Program will use the platform exclusively to assess commercial marketability of FDA-developed inventions. Tradespace is the sole vendor offering real-time market intelligence integrated with patent and IP portfolio analytics in a single solution tailored for government technology transfer workflows, with proprietary AI models and isolated private instances to protect pre-patent invention data.

The contract covers a one-year base period (September 30, 2026 through September 29, 2027) with three optional one-year renewal periods through September 29, 2030. Deliverables include platform access for two authorized FDA users, an onboarding plan due within three business days of award, live virtual training on platform navigation and commercialization workflows, continuous access to updated market intelligence data, and dedicated technical support during standard business hours (8:00 AM–6:00 PM Eastern Time, Monday–Friday). NAICS is 513210 (Software Publishers); PSC is DA10 (IT and Telecom—Business Application/Application Development Software as a Service). Pricing must be all-inclusive under Delivered Duty Paid Incoterms and submitted through the Treasury Invoice Processing Platform. The Government will evaluate total quoted price for fairness and reasonableness; best value is determined by technical acceptability and fair pricing. Responses must be submitted electronically to Min Jie Zeng at Minjie.Zeng@fda.hhs.gov. Solicitation number is 75F40126Q00438.